Allurion Technologies, Inc. Capital Expenditures Incurred but Not yet Paid
Allurion Technologies, Inc. (ALUR) reported Capital Expenditures Incurred but Not yet Paid of $31.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q/A filed 2025-08-28.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2025-08-28
- Allurion Technologies, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was -$42.00K.
- Allurion Technologies, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-03-31 was $73.00K, a 58.05% decline year-over-year.
- Allurion Technologies, Inc. capital expenditures incurred but not yet paid for the quarter ending 2023-12-31 was -$136.00K.
- Allurion Technologies, Inc. capital expenditures incurred but not yet paid for the quarter ending 2023-09-30 was $105.00K.
- Allurion Technologies, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $134.00K, a 930.77% increase from fiscal 2022.
- Allurion Technologies, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $13.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$42.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | $31.00K 10-Q/A · filed 2025-08-28 | -$105.00K derived: sum of 3 quarters · filed 2025-08-28 | $0.00 derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | $73.00K 10-Q/A · filed 2025-08-28 | -$63.00K derived: sum of 2 quarters · filed 2025-08-28 | $42.00K derived: sum of 3 quarters · filed 2025-08-28 | $33.00K derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | -$136.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | -$31.00K derived: sum of 2 quarters · filed 2025-08-28 | -$40.00K derived: sum of 3 quarters · filed 2025-08-28 | $134.00K 10-K/A · filed 2025-08-28 |
| 2023-09-30 | $105.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-08-28 | $96.00K derived: sum of 2 quarters · filed 2025-08-28 | $270.00K 10-Q/A · filed 2025-08-28 | $240.00K derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | -$9.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | $165.00K 10-Q/A · filed 2025-08-28 | $135.00K derived: sum of 3 quarters · filed 2025-08-28 | |
| 2023-03-31 | $174.00K 10-Q/A · filed 2025-08-28 | $144.00K derived: sum of 2 quarters · filed 2025-08-28 | ||
| 2022-12-31 | -$30.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $13.00K 10-K/A · filed 2025-08-28 | ||
| 2022-09-30 | $43.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |